Caprock Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.8M Buy
+58,683
New +$12.8M 0.47% 45

Other funds holding AXSM

Caprock Group's AXSM Position: Q3 2026 in Review

Caprock Group opened a new position in Axsome Therapeutics (AXSM) in Q3 2026: 58,683 shares worth $10.8M. The stake represents 0.47% of the portfolio and ranks #45 among its holdings.

465 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Caprock Group held 58,683 shares of Axsome Therapeutics worth $10.8M as of Q3 2026.
  • Axsome Therapeutics was a new Caprock Group position in Q3 2026.
  • Axsome Therapeutics made up 0.47% of Caprock Group's portfolio in Q3 2026, its #45 holding.
  • 465 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Caprock Group's 13F filing for Q3 2026, filed 17 Nov 2026.